Mizuki Yamamoto

6PUBLICATIONS
17CO-AUTHORS
Molecular targetsProteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 01, 2025
Tob negatively regulates NF-κB activation in breast cancer through its association with the TNF receptor complex.

Miho Tokumasu, Atsuko Sato, Taku Ito-Kureha

|May 27, 2023
In Silico and In Vitro Evaluation of Some Amidine Derivatives as Hit Compounds towards Development of Inhibitors against Coronavirus Diseases.

Ahmed H E Hassan, Selwan M El-Sayed, Mizuki Yamamoto

|Dec 16, 2022
Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19.

Hideki Ogura, Jin Gohda, Xiuyuan Lu

|Dec 29, 2020
The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.

Mizuki Yamamoto, Takeshi Ichinohe, Aya Watanabe

|Jun 14, 2020
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.

Mizuki Yamamoto, Maki Kiso, Yuko Sakai-Tagawa

|Aug 10, 2019
TRAF6 maintains mammary stem cells and promotes pregnancy-induced mammary epithelial cell expansion.

Mizuki Yamamoto, Chiho Abe, Sakura Wakinaga

Pageof 1

Frequent Collaborators

5 joint publications

Jun-Ichiro Inoue

1 joint publications

Makoto Takeda

1 joint publications

Takeshi Ichinohe

1 joint publications

Hideki Ogura